Med. praxi. 2014;11(1):30-33

Symptoms and risks of lung cancer

prof.MUDr.Jana Skřičková, CSc., MUDr.Bohdan Kadlec, Ph.D.
Klinika nemocí plicních a TBC LF MU a FN Brno

Twenty-five percent of all the patients are younger than 60 years. In the Czech Republic, lung cancer is diagnosed in an advanced

disease state. Over 60% of patients of both sexes are diagnosed in advanced stages. Exogenous factors undoubtedly play the main

role in the development of lung cancer: biological (viruses), physical (ionizing radiation), and particularly chemical (carcinogens).

Once symptoms appear, the cancer is already in an advanced stage. Symptoms are divided into three groups: intrathoracic or local

pulmonary symptoms (their occurrence depends primarily on the localization of the tumor), extrathoracic or metastatic, and paraneoplastic

symptoms and signs.

Keywords: lung cancer, epidemiology, symptoms, paraneoplastic syndromes

Published: February 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Skřičková J, Kadlec B. Symptoms and risks of lung cancer. Med. praxi. 2014;11(1):30-33.
Download citation

References

  1. Dušek L, Májek O, Mužík J, Koptíková J, Pavlík T, Skřičková J. Epidemiologie zhoubných nádorů plic, průdušnice a průdušek v ČR. In: Skřičková, V. Kolek a kol: Základy moderní pneumoonkologie. Maxdorf, Praha 2012: 490.
  2. Zatloukal P, Petruželka L. Karcinom plic. Praha: Grada; 2001.
  3. Pešek M, et al. Bronchogenní karcinom. Galén, Praha, 2002: 235.
  4. Skřičková J. Nádory plic a půdušek - Karcinom plic (287-302), Kolek V, Kašák V, Vašáková M.et al Pneumologie, 1 vydání, Maxdorf, Brno 2011: 552.
  5. Skřičková J, Kolek V, a kol. Základy moderní pneumoonkologie. Maxdorf, Praha 2012: 490.
  6. Ginsberg RJ. Lung Cancer. BC Decker Hamilton, London, 2002: 175.
  7. Adam Z, Vorlíček J, Fojtík Z, Šťourač P, Vašků V, Skorkovská Š. Systémové a paraneoplastické projevy maligních onemocnění Postgraduální medicína 2004; 6: 364-372.
  8. Adam Z. A kolektiv: Systémové a paraneoplastické projevy maligních onemocnění. Vnitř Lék 2007; 53(3): 253-285. Go to PubMed...
  9. Hansen M. Paraneoplastic syndromes and tumor markers for small-cell and non-small-cell lungcancer. Curr Opin Oncol 1990; 2: 345-351. Go to original source... Go to PubMed...
  10. Ilias K, Torpy D, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing's syndrome due to ectopic corticotropin secretion. J Clin Endocrinol Metab 2005; 90: 4955-4962. Go to original source... Go to PubMed...
  11. List AF, Hainsworth JD, Davis BW, Hande KR, Greco FA, Johnson DH. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lungcancer. J ClinOncol 1986; 4: 1191-1198. Go to original source... Go to PubMed...
  12. Török L. Kožní projevy při chorobách vnitřních orgánů. J. A. BarthVerlag Heidelberg Leipzig a ČLS J. E. Purkyně Praha 1998: 228.
  13. Rowland LP. Paraneoplastic syndromes. In: Rowland LP. Merritt´s Neurology, 10th ed. Lippincott Williams&Wilkins, Philadelphia 2000: 893-896.
  14. Štourač P. Autoimunitní paraneoplastická encefalomyelitida/senzitivní polyneuropatie - klinická a imunologická analýza. Čes a Slov Neurol Neurochir 2000; 5: 274-278.
  15. Verschuuren JJ, Wirtz PW, Titulaer MJ, Willems LN, van Gerven J. Available treatment for the management of Lambert-Eaton myasthenic syndrome. Expert Opin Pharmacother 2006; 7: 1323-1336. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.